CSMD1 Mutation Related to Immunity Can Be Used as a Marker to Evaluate the Clinical Therapeutic Effect and Prognosis of Patients with Esophageal Cancer
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.